Abstract
The present invention relates to the field of cancer therapy, specifically to potent RNA inhibitory molecules silencing the expression of Voltage-Dependent Ion Chanel- (VDAC1) and to the use of RNA inhibitory molecules for treating cancer.
| Original language | English |
|---|---|
| Patent number | WO2020089906 |
| IPC | A61P 35/ 00 A I |
| Priority date | 27/06/19 |
| State | Published - 7 May 2020 |